Cargando…
Artificial Intelligence Approach for Variant Reporting
PURPOSE: Next-generation sequencing technologies are actively applied in clinical oncology. Bioinformatics pipeline analysis is an integral part of this process; however, humans cannot yet realize the full potential of the highly complex pipeline output. As a result, the decision to include a varian...
Autores principales: | Zomnir, Michael G., Lipkin, Lev, Pacula, Maciej, Dominguez Meneses, Enrique, MacLeay, Allison, Duraisamy, Sekhar, Nadhamuni, Nishchal, Al Turki, Saeed H., Zheng, Zongli, Rivera, Miguel, Nardi, Valentina, Dias-Santagata, Dora, Iafrate, A. John, Le, Long P., Lennerz, Jochen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198661/ https://www.ncbi.nlm.nih.gov/pubmed/30364844 http://dx.doi.org/10.1200/CCI.16.00079 |
Ejemplares similares
-
Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma
por: Thierauf, Julia, et al.
Publicado: (2019) -
BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications
por: Dias-Santagata, Dora, et al.
Publicado: (2011) -
Pulmonary adenocarcinoma mutation profile in smokers with smoking-related interstitial fibrosis
por: Primiani, Andrea, et al.
Publicado: (2014) -
Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms
por: Tsai, Harrison K., et al.
Publicado: (2020) -
t(4;12)(q12;p13) ETV6-rearranged AML without eosinophilia does not involve PDGFRA: relevance for imatinib insensitivity
por: Mueller, Sarah B., et al.
Publicado: (2022)